Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Language
Publication year range
1.
Indian J Otolaryngol Head Neck Surg ; 76(3): 2850-2854, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38883445

ABSTRACT

We presented a case of a 46-year-old woman from Saudi Arabia with a persistent buccal ulcer, measuring 0.4 × 0.4 × 0.3 cm. After surgical excision of the lesion was performed using both general and local anesthesia, its microscopic examination revealed keratinized squamous epithelium with surface ulcerations in the buccal mucosa. Beneath the epithelium, there was granulation tissue, scattered and clustered lymphoid tissue, and reactive germinal centers with tingible body microphages. These lymphoid clusters infiltrated the adjacent skeletal muscles and fat. The final diagnosis was ectopic oral tonsillar tissue overlaid by an inflammatory ulcer, most likely attributed to friction. Importantly, no evidence of malignancy were observed in the biopsy. The surgical removal of the lesion was performed to rule out malignancy. The surgical excision was performed using both general and local anesthesia. Following surgery and during follow-up visits, the indicated instructions were provided. Pain was effectively managed with acetaminophen, and the patient fully recovered in approximately ten days. Neither recurrence nor post-operative complications were hitherto reported. Supplementary Information: The online version contains supplementary material available at 10.1007/s12070-024-04536-8.

2.
J Oral Biol Craniofac Res ; 7(2): 101-105, 2017.
Article in English | MEDLINE | ID: mdl-28706783

ABSTRACT

BACKGROUND: Ameloblastoma (AM) and odontogenic Keratocyst (OKC) are destructive odontogenic lesions of the gnathion. Although their exact pathogeneses are not yet totally understood, the viral etiopathogenesis in AM and KCOT has been proposed. True to syndromic keratocystic odontogenic tumor (sKCOT) and non-syndromic OKC is the high recurrence rate. OBJECTIVES: Given that shared pathways trailed by AM and by sKCOT/OKC have been suggested, this study, however, contrasts the expression of AM and OKC for viral antibodies. METHOD: A total of archival 80 paraffin blocks of cases of parakeratinized odontogenic keratocyst (non-syndromic KCOTs) and of ameloblastomas (n = 40 for each) were included in this study to be sectioned and stained for two immunohistochemical markers: anti-human papillomavirus and Epstein-Barr virus-encoded latent membrane protein. RESULTS: All the submitted cases of AM and parakeratinized OKC were negative for both markers: anti-HPV and anti-LMP-1. CONCLUSIONS: Although results could have been biased, given the same ethnic group and territory examined in this study, all cases were negative for both markers. Therefore, the viral contribution to the etiopathogenesis in AM and OKC could not be established in this study.

3.
Head Neck ; 39(6): 1243-1248, 2017 06.
Article in English | MEDLINE | ID: mdl-28370824

ABSTRACT

BACKGROUND: Mammary analog secretory carcinoma of the salivary glands (MASCSG ) is a newly introduced malignant tumor of the salivary glands. For decades, it has been confused with acinic cell carcinoma (ACC) of the salivary glands. METHODS: All reported cases of MASCSG were surveyed from 2010 until January 2017. The collected data was compiled and computationally processed to describe the clinical parameters of MASCSG . Its epidemiology was also mapped. Moreover, inaccurate data was highlighted. RESULTS: Clinically implicating, this article tackles simply the several clinical findings of MASCSG so that our contemporary nosology, at 7 years after description, can be updated. The cytogenetic, histologic, and immunohistochemical details are also defined. CONCLUSION: The available data about MASCSG is sufficient enough to diagnose it with no need to investigate the ETV6-NTRK3 translocation. Although high-grade malignancy and distant metastases were rarely reported, a rapt attention should be paid both to the nature of this tumor and to the indicated close follow-up of such cases, especially when necrosis, increased mitotic activity, and other classic caveats are conspicuous. © 2017 Wiley Periodicals, Inc. Head Neck 39: 1243-1248, 2017.


Subject(s)
Mammary Analogue Secretory Carcinoma/epidemiology , Mammary Analogue Secretory Carcinoma/genetics , Mammary Analogue Secretory Carcinoma/pathology , Salivary Gland Neoplasms/epidemiology , Salivary Gland Neoplasms/genetics , Salivary Gland Neoplasms/pathology , Adult , Aged , Biopsy, Needle , Combined Modality Therapy , Disease-Free Survival , Female , Gene Expression Regulation, Neoplastic , Humans , Immunohistochemistry , Internationality , Male , Mammary Analogue Secretory Carcinoma/therapy , Middle Aged , Prognosis , Proto-Oncogene Proteins c-ets/genetics , Repressor Proteins/genetics , Risk Assessment , Salivary Gland Neoplasms/therapy , Survival Analysis , Time Factors , ETS Translocation Variant 6 Protein
6.
Ann Diagn Pathol ; 22: 18-24, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27180055

ABSTRACT

This study aims at investigating the pathogenesis and oncogenesis of ameloblastoma. Being the commonest odontogenic tumor with idiopathic nature, ameloblastoma poses a fierce controversy about its oncogenesis. Immunohistochemical markers, over years, have highlighted specific pathways which are inherently undertaken in the tumorigenic process of ameloblastoma. Besides the recently pronounced clue of BRAF V600E mutant gene, this study introduces a new marker with its outstanding impact on our contemporary knowledge about ameloblastoma. Extrapolating from the systematic review of medical literature and recruiting a novel immunohistochemical marker, ameloblastoma enacts a new scenario supporting the approved involvement of MAPK by overexpressing WT1 a total of 37 archival cases, regardless of the histological variant in study. There evinces a significant contribution of Wilm's tumor gene, as an oncogene rather than a suppressor gene, to the pathogenesis of the ameloblastomatous tumorigenesis. Moreover, no ameloblastomatous histological phenotype has established, given the literature underpinned, a concrete impact on the clinical behavior. Immunohistochemical research papers which investigated tumorigenesis - although they do not quantitatively measure much- had the most significant impact on the diagnostic and prognostic levels. WT1 may play, therefore, a remarkable role in the oncogenesis of ameloblastoma.


Subject(s)
Ameloblastoma/metabolism , Ameloblastoma/pathology , Biomarkers, Tumor/analysis , Carcinogenesis/pathology , Immunohistochemistry , Odontogenic Tumors/metabolism , Biomarkers, Tumor/metabolism , Humans , Immunohistochemistry/methods , Odontogenic Tumors/pathology , Phenotype
7.
Rev. esp. patol ; 49(1): 19-22, ene.-mar. 2016. ilus
Article in English | IBECS | ID: ibc-149060

ABSTRACT

Bizarre parosteal osteochondromatous proliferation (BPOP), or eponymically Nora's lesion, is a rare growing, to a certain extent, exophytic lesion usually emanating from the periosteum or its adjacent layers. BPOP is idiopathically painful. Given its cartilage-producing nature and pain, BPOP is viewed with great suspicion. Regular post-surgical radiographs and clinical follow-up are mandatory. In the gnathic bones, the lesion is extremely rare. To the author's best knowledge, this paper reports the sophomoric appearance of BPOP in the anterior maxilla, in an adult female (AU)


La proliferación paraosteal osteocondromatosa bizarra (PPOB), o lesión de Nora según su epónimo, es un crecimiento inusual, exofítico, que procede del periostio o sus capas adyacentes. La PPOB es idiopáticamente dolorosa. Dada su naturaleza cartilaginosa y el dolor que la acompaña, la PPOB resulta una lesión sospechosa. Son obligatorios el estudio radiológico y seguimiento clínico postquirúrgicos. En los huesos maxilares, esta lesión es extremadamente infrecuente. En lo que conoce el autor, este artículo es la primera descripción de la PPOB de maxilar, en una mujer adulta (AU)


Subject(s)
Humans , Female , Adult , Maxillary Diseases/pathology , Maxillary Diseases , Maxillary Diseases/surgery , Osteochondromatosis/complications , Osteochondromatosis , Osteochondromatosis/surgery , Maxilla/pathology , Maxilla , Periosteum/pathology , Periosteum , /methods , Photomicrography/instrumentation , Photomicrography/methods , Photomicrography , Chondrocytes/pathology , Immunohistochemistry/methods , Immunohistochemistry
SELECTION OF CITATIONS
SEARCH DETAIL